, where IOPAvW is weighted average IOP, mm Hg, IOP1 = average IOP level of initial mode, mm Hg, IOPn – average IOP level using the following initial antihypertensive regimen, mm Hg, T1 – duration of initial mode use, months/years, Tn – duration of use following initial hypotensive mode, T – duration of glaucoma, months/years. If IOPAvW is 20 mm Hg or less, the mode of drug-induced antihypertensive therapy is not changed. If IOPAvW is 21–23 mm Hg, the correction of the drug-induced antihypertensive therapy is performed, or laser surgical treatment is performed additionally. If IOPAvW value is more than 23 mm Hg. surgical treatment is performed.;EFFECT: method provides prolonged preservation of visual functions and increased duration of transition of the initial stage of glaucoma into the advanced stage due to higher accuracy of determining therapeutic approach to the initial stage of primary open-angle glaucoma.;1 cl, 3 ex, 1 tbl"/>
公开/公告号RU2681705C1
专利类型
公开/公告日2019-03-12
原文格式PDF
申请/专利号RU20180112165
发明设计人 ZAKHAROVA MARIYA ANDREEVNA (RU);GORODNICHIJ VITALIJ VLADIMIROVICH (RU);KONDRAKOVA IRINA VLADIMIROVNA (RU);ZAVADSKIJ PAVEL CHESLAVOVICH (BY);KUROEDOV ALEKSANDR VLADIMIROVICH (RU);
申请日2018-04-04
分类号A61B3/00;A61B3/16;
国家 RU
入库时间 2022-08-21 11:46:20